Review Product Marketing Authorisation For Veterinary Use «Ronaxan»

Original Language Title: Modifica dell'autorizzazione all'immissione in commercio delmedicinale per uso veterinario «Ronaxan»

Read the untranslated law here: http://www.gazzettaufficiale.it/atto/serie_generale/caricaArticoloDefault/originario?atto.dataPubblicazioneGazzetta=2015-02-09&atto.codiceRedazionale=15A00787&elenco30giorni=false&atto.tipoProvvedimento=DECRETO

Retrieved 11 January 8, 2015 # the provision of veterinary medicinal product RONAXAN (A.I.C. # 100327).
Packaging: 20 tablets of 20 mg-A.I.C. # 100327016;
10 mg 100 tablets-A.I.C. # 100327028;
10 tablets of 250 mg-A.I.C. # 100327030.
A.I.C. holder: Merial Italy S.p.A. with registered office in via Vittor Pisani, 16-Milano.
The subject of the order: type II variation: b. II. 3. b) 2.
Changes of qualitative and quantitative composition of the finished product.
You authorize, for the product shown in the object, modifying the qualitative and quantitative composition as indicated in pharmaceutical techniques acquired to acts.
Lots already products can be marketed until expiration date.
This abstract will be published in the official journal of the Italian Republic, and its decision will be notified to the undertaking in question.